Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity, inflammation, and beta-cell function, offering potential benefits for Type 2 Diabetes Mellitus prevention and management.
FDA clears PK Med to streamline gout injectable to Phase II – Pharmaceutical Technology
Share this article The number of diagnosed prevalent cases of gout will be 25,961,819 in 2032, according to GlobalData. Credit: ThamKC via Shutterstock. France-based biotechnology